EMSYN MET 12.5+500MG TAB

EMSYN MET combines empagliflozin and metformin HCL in a single tablet for effective diabetes management. Each tablet contains 12.5mg empagliflozin and 500mg metformin HCL, working together to help regulate blood sugar levels. Empagliflozin promotes glucose excretion through urine, while metformin reduces hepatic glucose production and improves insulin sensitivity. Ideal for patients with type 2 diabetes who require dual-action glycemic control. Take as directed by your healthcare provider. Store in a cool, dry place away from moisture and direct sunlight.